Educational clinical resource

Suspected fetal infection: CMV, parvovirus B19, imaging, and diagnosis

Maternal infection does not always mean fetal disease; timing, serology, ultrasound, Doppler, amniocentesis, and follow-up define the real risk.

Medical leadDr. Ali Al-IbrahimContent updated
Conceptual visual atlas supporting this Suspected fetal infection: CMV, parvovirus B19, imaging, and diagnosis fetal therapy guide
  1. 01Fetal transfusion
  2. 02TTTS laser
  3. 03FETO
  4. 04Shunts & drainage
Conceptual therapy atlasGeneral educational artwork—not patient-specific anatomy or procedural instruction.
Visual guide map

How to navigate Suspected fetal infection: CMV, parvovirus B19, imaging, and diagnosis

An educational path from the first question to the next step. It does not replace individual assessment.

  1. 01Recognise the finding

    Name the maternal, fetal, placental, or pregnancy concern precisely.

  2. 02Confirm what it means

    Check gestation, diagnostic criteria, severity, and possible alternatives.

  3. 03Stratify risk

    Identify what changes maternal safety, fetal wellbeing, timing, or prognosis.

  4. 04Plan surveillance

    Match monitoring intensity to the condition and how quickly it can change.

  5. 05Escalate when needed

    Refer, admit, treat, or plan birth when thresholds are reached.

Maternal infection during pregnancy does not automatically mean that the fetus is infected, and fetal infection does not always mean that ultrasound abnormalities or long-term effects will occur. The assessment separates four questions: did maternal infection occur, could it have reached the fetus, is fetal infection demonstrated, and is there evidence that the fetus is affected?

The relevant tests and timing depend on the organism. Cytomegalovirus (CMV) and parvovirus B19 illustrate why a generic “infection screen” is not enough.

CMV

Maternal CMV serology may help establish whether infection is recent, past, or uncertain, but interpretation can require IgG, IgM, avidity, repeat samples, and clinical context. Amniotic-fluid testing can diagnose fetal infection when performed at an appropriate interval from maternal infection and gestational age.

A positive fetal test does not by itself predict severity. Detailed neurosonography, growth assessment, placental findings, amniotic fluid, and sometimes fetal MRI contribute to counselling. Some affected fetuses have no visible ultrasound signs, while some findings are non-specific.

Parvovirus B19

Parvovirus can suppress fetal red-cell production and cause anaemia, heart strain, and hydrops. Surveillance uses ultrasound and middle cerebral artery Doppler over the period of risk. If severe anaemia is suspected, fetal blood sampling and intrauterine transfusion assessment may be indicated.

Making sense of the result

Counselling should distinguish maternal exposure, maternal infection, fetal infection, and fetal disease. It should explain test sensitivity, timing, false reassurance from testing too early, uncertainty in long-term prognosis, and what postnatal testing or follow-up may be needed.

What to send for review

Provide the suspected exposure date, symptoms, all original and repeat serology with collection dates, laboratory method if available, gestational age, ultrasound and Doppler reports, original images, and any amniotic-fluid or genetic results. Avoid repeating tests without a defined question; changing laboratories or drawing samples too close together can make interpretation harder rather than clearer.

References

  1. ISUOG — Cytomegalovirus infection in pregnancy
  2. ISUOG — Parvovirus B19 infection in pregnancy
  3. ISUOG — Ultrasound in congenital infection guideline